GHRS
GH Research PLC
NASDAQ: GHRS · HEALTHCARE · BIOTECHNOLOGY
$20.53
+7.15% today
Updated 2026-04-30
Market cap
$1.26B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.79
Dividend yield
—
52W range
$9 – $25
Volume
0.2M
GH Research PLC (GHRS) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Total assets | $504000.00 | $5.91M | $279.92M | $254.36M | $226.30M | $188.27M |
| Cash & equivalents | $498000.00 | $5.89M | $276.78M | $165.96M | $78.42M | $100.79M |
| Current assets | $504000.00 | $5.91M | $279.84M | $168.54M | $164.09M | $154.22M |
| Total liabilities | $104000.00 | $246000.00 | $2.75M | $4.55M | $7.33M | $9.32M |
| Current liabilities | $104000.00 | $246000.00 | $2.75M | $4.55M | $6.70M | $8.95M |
| Long-term debt | — | — | — | — | — | — |
| Shareholder equity | $400000.00 | $5.67M | $277.18M | $249.82M | $218.97M | $178.95M |
| Retained earnings | $-389000.00 | $-835000.00 | $-10.04M | $-32.49M | $-67.94M | $-106.45M |
| Accounts receivable | — | $6000.00 | $48000.00 | $90000.00 | $178000.00 | $1.73M |
| Inventory | — | $-6000.00 | $3.01M | $-90000.00 | $-178000.00 | — |
| Goodwill | — | — | — | — | — | — |